|
1
|
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.
|
N Engl J Med
|
1997
|
18.85
|
|
2
|
Laboratory methods and quality assurance in the Cardiovascular Health Study.
|
Clin Chem
|
1995
|
7.73
|
|
3
|
Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).
|
Circulation
|
2000
|
7.37
|
|
4
|
Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.
|
Am J Med
|
1999
|
6.92
|
|
5
|
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.
|
JAMA
|
2005
|
5.60
|
|
6
|
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study.
|
J Am Coll Cardiol
|
2000
|
5.59
|
|
7
|
Serum IL-6 level and the development of disability in older persons.
|
J Am Geriatr Soc
|
1999
|
4.84
|
|
8
|
Variability in the measurement of C-reactive protein in healthy subjects: implications for reference intervals and epidemiological applications.
|
Clin Chem
|
1997
|
4.77
|
|
9
|
Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.
|
Am J Epidemiol
|
2000
|
4.16
|
|
10
|
Markers of inflammation and prediction of diabetes mellitus in adults (Atherosclerosis Risk in Communities study): a cohort study.
|
Lancet
|
1999
|
4.07
|
|
11
|
Relation of C-reactive protein and coronary heart disease in the MRFIT nested case-control study. Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1996
|
3.82
|
|
12
|
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases.
|
Eur J Epidemiol
|
2007
|
3.81
|
|
13
|
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification.
|
Lancet
|
1998
|
3.61
|
|
14
|
The relation of body fat mass and distribution to markers of chronic inflammation.
|
Int J Obes Relat Metab Disord
|
2001
|
3.39
|
|
15
|
Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease.
|
Circulation
|
1998
|
2.83
|
|
16
|
Association between physical activity and markers of inflammation in a healthy elderly population.
|
Am J Epidemiol
|
2001
|
2.68
|
|
17
|
The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study.
|
Diabetes
|
2001
|
2.47
|
|
18
|
Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study.
|
Atherosclerosis
|
2001
|
2.40
|
|
19
|
Increased blood glucose and insulin, body size, and incident colorectal cancer.
|
J Natl Cancer Inst
|
1999
|
2.40
|
|
20
|
Clinical efficacy of an automated high-sensitivity C-reactive protein assay.
|
Clin Chem
|
1999
|
2.35
|
|
21
|
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study.
|
Circulation
|
1999
|
2.31
|
|
22
|
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus.
|
Arthritis Rheum
|
1999
|
2.21
|
|
23
|
Inflammation in cardiovascular disease: cart, horse, or both?
|
Circulation
|
1998
|
2.18
|
|
24
|
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study.
|
Arterioscler Thromb Vasc Biol
|
1999
|
2.15
|
|
25
|
Lipoprotein lipids in older people. Results from the Cardiovascular Health Study. The CHS Collaborative Research Group.
|
Circulation
|
1992
|
1.79
|
|
26
|
Epidemiology of low cholesterol levels in older adults. The Cardiovascular Health Study.
|
Circulation
|
1993
|
1.75
|
|
27
|
Analytical and biologic variability in measures of hemostasis, fibrinolysis, and inflammation: assessment and implications for epidemiology.
|
Am J Epidemiol
|
1999
|
1.73
|
|
28
|
Prevalence of cardiovascular diseases among older adults. The Cardiovascular Health Study.
|
Am J Epidemiol
|
1993
|
1.63
|
|
29
|
Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: The Insulin Resistance Atherosclerosis Study.
|
Kidney Int
|
2000
|
1.62
|
|
30
|
T helper-cell phenotype regulates atherosclerosis in mice under conditions of mild hypercholesterolemia.
|
Circulation
|
2001
|
1.57
|
|
31
|
Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment.
|
Ann Neurol
|
1991
|
1.46
|
|
32
|
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
|
Am J Cardiol
|
1996
|
1.46
|
|
33
|
Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS).
|
Arterioscler Thromb Vasc Biol
|
1999
|
1.37
|
|
34
|
Black-white differences in subclinical cardiovascular disease among older adults: the Cardiovascular Health Study. CHS Collaborative Research Group.
|
J Clin Epidemiol
|
1995
|
1.34
|
|
35
|
Fat distribution and hemostatic measures in obese children.
|
Am J Clin Nutr
|
1998
|
1.31
|
|
36
|
The reliability of medication inventory methods compared to serum levels of cardiovascular drugs in the elderly.
|
J Clin Epidemiol
|
1999
|
1.31
|
|
37
|
Diabetes mellitus and echocardiographic left ventricular function in free-living elderly men and women: The Cardiovascular Health Study.
|
Am Heart J
|
1997
|
1.29
|
|
38
|
"Clotspeed," a mathematical simulation of the functional properties of prothrombinase.
|
J Biol Chem
|
1984
|
1.28
|
|
39
|
Systematically missing confounders in individual participant data meta-analysis of observational cohort studies.
|
Stat Med
|
2009
|
1.27
|
|
40
|
Longitudinal stability of coagulation, fibrinolysis, and inflammation factors in stored plasma samples.
|
Thromb Haemost
|
2001
|
1.27
|
|
41
|
Sex- and race-related differences in liver-associated serum chemistry tests in young adults in the CARDIA study.
|
Clin Chem
|
1992
|
1.23
|
|
42
|
Sonographic evaluation of carotid artery atherosclerosis in the elderly: relationship of disease severity to stroke and transient ischemic attack.
|
Radiology
|
1993
|
1.23
|
|
43
|
Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study.
|
Circulation
|
2000
|
1.22
|
|
44
|
Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect.
|
Arterioscler Thromb Vasc Biol
|
2001
|
1.21
|
|
45
|
Two-dimensional gel electrophoresis of serum specimens from a normal population.
|
Clin Chem
|
1982
|
1.21
|
|
46
|
Association of C-reactive protein with markers of prevalent atherosclerotic disease.
|
Am J Cardiol
|
2001
|
1.20
|
|
47
|
Respiratory muscle strength and the risk of incident cardiovascular events.
|
Thorax
|
2004
|
1.20
|
|
48
|
The prospective association between adiponectin and coronary artery disease among individuals with type 1 diabetes. The Pittsburgh Epidemiology of Diabetes Complications Study.
|
Diabetologia
|
2004
|
1.18
|
|
49
|
Plasma fibrinogen: levels and correlates in young adults. The Coronary Artery Risk Development in Young Adults (CARDIA) Study.
|
Am J Epidemiol
|
1993
|
1.16
|
|
50
|
Association between patterns of nucleotide variation across the three fibrinogen genes and plasma fibrinogen levels: the Coronary Artery Risk Development in Young Adults (CARDIA) study.
|
J Thromb Haemost
|
2006
|
1.15
|
|
51
|
Physical activity and physiological cardiac remodelling in a community setting: the Multi-Ethnic Study of Atherosclerosis (MESA).
|
Heart
|
2009
|
1.13
|
|
52
|
The relation between serum albumin levels and risk of coronary heart disease in the Multiple Risk Factor Intervention Trial.
|
Am J Epidemiol
|
1991
|
1.12
|
|
53
|
Thrombin generation, inhibition and clinical outcomes in patients with acute myocardial infarction treated with thrombolytic therapy and heparin: results from the GUSTO-I Trial. GUSTO-I Hemostasis Substudy Group. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries.
|
J Am Coll Cardiol
|
1998
|
1.10
|
|
54
|
Plasma fibrinogen as a predictor of total and cause-specific mortality in elderly Japanese-American men.
|
Arterioscler Thromb Vasc Biol
|
2001
|
1.08
|
|
55
|
Human platelets contain and secrete osteonectin, a major protein of mineralized bone.
|
Proc Natl Acad Sci U S A
|
1986
|
1.07
|
|
56
|
The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial.
|
J Clin Endocrinol Metab
|
2000
|
1.06
|
|
57
|
Is visceral adiposity the "enemy within"?
|
Arterioscler Thromb Vasc Biol
|
2001
|
1.04
|
|
58
|
Hormone replacement therapy, inflammation, and hemostasis in elderly women.
|
Arterioscler Thromb Vasc Biol
|
1999
|
1.04
|
|
59
|
Soluble intracellular adhesion molecule-1 is associated with cardiovascular disease risk and mortality in older adults.
|
J Thromb Haemost
|
2006
|
1.03
|
|
60
|
Plasma lipoproteins support prothrombinase and other procoagulant enzymatic complexes.
|
Arterioscler Thromb Vasc Biol
|
1998
|
1.02
|
|
61
|
Summary of the scientific conference on dietary fatty acids and cardiovascular health: conference summary from the nutrition committee of the American Heart Association.
|
Circulation
|
2001
|
1.02
|
|
62
|
Sudden cardiac death, genes, and arrhythmogenesis : consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I.
|
Circulation
|
2001
|
1.01
|
|
63
|
Serum levels of C-reactive protein are associated with obesity, weight gain, and hormone replacement therapy in healthy postmenopausal women.
|
Am J Epidemiol
|
2001
|
1.00
|
|
64
|
Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women.
|
Arterioscler Thromb Vasc Biol
|
1999
|
1.00
|
|
65
|
Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.
|
Am J Epidemiol
|
1996
|
1.00
|
|
66
|
TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial.
|
Circulation
|
1997
|
0.99
|
|
67
|
The prognostic value of serum albumin in healthy older persons with low and high serum interleukin-6 (IL-6) levels.
|
J Am Geriatr Soc
|
2000
|
0.98
|
|
68
|
Asthma and its association with cardiovascular disease in the elderly. The Cardiovascular Health Study Research Group.
|
J Asthma
|
1996
|
0.98
|
|
69
|
C-reactive protein is more strongly related to post-glucose load glucose than to fasting glucose in non-diabetic subjects; the Insulin Resistance Atherosclerosis Study.
|
Diabet Med
|
2002
|
0.97
|
|
70
|
Sample preparation for plasma measurement of plasminogen activator inhibitor-1 antigen in large population studies.
|
Arch Pathol Lab Med
|
1993
|
0.96
|
|
71
|
Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction.
|
J Am Coll Cardiol
|
1999
|
0.96
|
|
72
|
Growth on type I collagen promotes expression of the osteoblastic phenotype in human osteosarcoma MG-63 cells.
|
J Cell Physiol
|
1992
|
0.95
|
|
73
|
Rebound increase in thrombin generation and activity after cessation of intravenous heparin in patients with acute coronary syndromes.
|
Circulation
|
1995
|
0.95
|
|
74
|
Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study.
|
J Thromb Haemost
|
2009
|
0.94
|
|
75
|
Evidence that meizothrombin is an intermediate product in the clotting of whole blood.
|
Arterioscler Thromb Vasc Biol
|
1995
|
0.94
|
|
76
|
Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
|
Stroke
|
1997
|
0.93
|
|
77
|
Sudden cardiac death, genes, and arrhythmogenesis: consideration of new population and mechanistic approaches from a National Heart, Lung, and Blood Institute workshop, Part II.
|
Circulation
|
2001
|
0.93
|
|
78
|
The measurement of fibrinogen in population-based research. Studies on instrumentation and methodology.
|
Arch Pathol Lab Med
|
1994
|
0.92
|
|
79
|
Monoclonal antibodies to native noncollagenous bone-specific proteins.
|
Proc Natl Acad Sci U S A
|
1984
|
0.92
|
|
80
|
Heterogeneity of human bone.
|
J Bone Miner Res
|
1990
|
0.90
|
|
81
|
The mechanism of inactivation of human platelet factor Va from normal and activated protein C-resistant individuals.
|
J Biol Chem
|
1995
|
0.90
|
|
82
|
Effect of short-term aspirin use on C-reactive protein.
|
J Thromb Thrombolysis
|
2000
|
0.90
|
|
83
|
Coronary risk assessment among intermediate risk patients using a clinical and biomarker based algorithm developed and validated in two population cohorts.
|
Curr Med Res Opin
|
2012
|
0.90
|
|
84
|
Associations of postmenopausal estrogen use with cardiovascular disease and its risk factors in older women. The CHS Collaborative Research Group.
|
Circulation
|
1993
|
0.90
|
|
85
|
Mathematical simulation of prothrombinase.
|
Methods Enzymol
|
1992
|
0.89
|
|
86
|
Correlates of antithrombin, protein C, protein S, and TFPI in a healthy elderly cohort.
|
Thromb Haemost
|
1998
|
0.88
|
|
87
|
Novel gene variants predict serum levels of the cytokines IL-18 and IL-1ra in older adults.
|
Cytokine
|
2013
|
0.88
|
|
88
|
Eligibility for cholesterol referral in community-dwelling older adults. The Cardiovascular Health Study.
|
Ann Intern Med
|
1992
|
0.88
|
|
89
|
Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease.
|
Arterioscler Thromb Vasc Biol
|
1996
|
0.88
|
|
90
|
Beta 2-microglobulin determined by radioimmunoassay with monoclonal antibody.
|
Clin Chem
|
1982
|
0.87
|
|
91
|
Inflammation markers and incident venous thromboembolism: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort.
|
J Thromb Haemost
|
2014
|
0.86
|
|
92
|
Osteocalcin and osteonectin immunoreactivity in the diagnosis of osteosarcoma.
|
Am J Clin Pathol
|
1997
|
0.86
|
|
93
|
Relations of plasma fibrinogen level in children to measures of obesity, the (G-455-->A) mutation in the beta-fibrinogen promoter gene, and family history of ischemic heart disease: the Columbia University BioMarkers Study.
|
Am J Epidemiol
|
1999
|
0.86
|
|
94
|
Is type 2 diabetes a chronic inflammatory/autoimmune disease?
|
Diabetes Nutr Metab
|
2002
|
0.85
|
|
95
|
Role of tumor necrosis factor-alpha and interleukin-6 in the effects of hormone replacement therapy and raloxifene on C-reactive protein in postmenopausal women.
|
Am J Cardiol
|
2001
|
0.85
|
|
96
|
Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction.
|
Blood
|
1990
|
0.84
|
|
97
|
Minimal genetic influences on plasma fibrinogen level in adult males in the NHLBI twin study.
|
Clin Genet
|
1994
|
0.84
|
|
98
|
Identification of the noncollagenous proteins of bovine bone by two-dimensional gel electrophoresis.
|
Calcif Tissue Int
|
1984
|
0.84
|
|
99
|
Quantitative trait locus on chromosome 12q14.1 influences variation in plasma plasminogen levels in the San Antonio Family Heart Study.
|
Hum Biol
|
2007
|
0.83
|
|
100
|
Factor VII antigen levels in a healthy blood donor population.
|
Thromb Haemost
|
1994
|
0.83
|
|
101
|
A densitometer based on a microcomputer and TV camera, for use in the clinical laboratory.
|
Clin Chem
|
1984
|
0.83
|
|
102
|
Active site-specific immunoassays.
|
Blood
|
1990
|
0.83
|
|
103
|
LDL particle size in relation to insulin, proinsulin, and insulin sensitivity. The Insulin Resistance Atherosclerosis Study.
|
Diabetes Care
|
1999
|
0.83
|
|
104
|
Molecular characterization of commercial porcine factor VIII concentrate.
|
Blood
|
1988
|
0.83
|
|
105
|
Distribution and correlates of plasma fibrinogen in middle-aged women. Initial findings of the Postmenopausal Estrogen/Progestin Interventions (PEPI) study.
|
Arterioscler Thromb Vasc Biol
|
1995
|
0.82
|
|
106
|
Current estrogen-progestin and estrogen replacement therapy in elderly women: association with carotid atherosclerosis. CHS Collaborative Research Group. Cardiovascular Health Study.
|
Ann Epidemiol
|
1996
|
0.82
|
|
107
|
The role of inflammation in cardiovascular disease.
|
Arterioscler Thromb Vasc Biol
|
2000
|
0.81
|
|
108
|
Identification of a vitamin D-responsive protein on the surface of human osteosarcoma cells.
|
Proc Natl Acad Sci U S A
|
1989
|
0.81
|
|
109
|
Intermediate filament proteins in asbestos-induced mesotheliomas of the rat.
|
Cancer Res
|
1987
|
0.81
|
|
110
|
Effects of physical training and its cessation on the hemostatic system of obese children.
|
Am J Clin Nutr
|
1999
|
0.81
|
|
111
|
Factor V Leiden is not a risk factor for arterial vascular disease in the elderly: results from the Cardiovascular Health Study.
|
Thromb Haemost
|
1998
|
0.80
|
|
112
|
AHA scientific statement: summary of the Scientific Conference on Dietary Fatty Acids and Cardiovascular Health. Conference summary from the Nutrition Committee of the American Heart Association.
|
J Nutr
|
2001
|
0.80
|
|
113
|
Analysis of electrophoretic behavior of cytochrome c oxidase subunits. Retardation coefficient versus molecular weight in dodecyl sulfate urea gels.
|
Biochim Biophys Acta
|
1979
|
0.80
|
|
114
|
Adhesion molecules, endothelin-1 and lung function in seven population-based cohorts.
|
Biomarkers
|
2013
|
0.80
|
|
115
|
Lack of association of the plasminogen activator inhibitor-1 4G/5G promoter polymorphism with cardiovascular disease in the elderly.
|
J Thromb Haemost
|
2003
|
0.79
|
|
116
|
Simultaneous measurement of total and IgA-conjugated alpha 1-microglobulin by a combined immunoenzyme/immunoradiometric assay technique.
|
Clin Chem
|
1989
|
0.79
|
|
117
|
Two-dimensional gel electrophoresis of serum specimens from patients with monoclonal gammopathies.
|
Clin Chem
|
1982
|
0.79
|
|
118
|
Characterization of platelet activation and thrombin generation accompanying percutaneous transluminal coronary angioplasty.
|
Coron Artery Dis
|
1995
|
0.79
|
|
119
|
Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardiaL infarction. Thrombolysis in Myocardial Ischemia III B Investigators.
|
Am Heart J
|
1996
|
0.79
|
|
120
|
The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. TIMI-III Thrombosis and Anticoagulation Group.
|
Coron Artery Dis
|
1994
|
0.79
|
|
121
|
Inverse association of physical fitness with plasma fibrinogen level in children: the Columbia University BioMarkers Study.
|
Am J Epidemiol
|
2000
|
0.79
|
|
122
|
Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.
|
Thromb Haemost
|
1999
|
0.79
|
|
123
|
Simultaneous determination of cerebrospinal fluid oligoclonal bands and the "gamma-protein index" by agarose electrophoresis and densitometry.
|
Clin Chem
|
1986
|
0.78
|
|
124
|
Prediction and classification of cardiovascular disease risk in older adults with diabetes.
|
Diabetologia
|
2012
|
0.78
|
|
125
|
Methodology for high-resolution two-dimensional gel electrophoresis.
|
Cancer Invest
|
1987
|
0.78
|
|
126
|
Plasminogen activator inhibitor-1 and the risk of Type 2 diabetes mellitus in American Indians: the Strong Heart Study.
|
Diabet Med
|
2006
|
0.78
|
|
127
|
Immunological studies on cytochrome c oxidase: arrangements of protein subunits in the solubilized and membrane-bound enzyme.
|
Eur J Biochem
|
1978
|
0.78
|
|
128
|
Inhibition of platelet aggregation with a glycoprotein IIb-IIIa antagonist does not prevent thrombin generation in patients undergoing thrombolysis for acute myocardial infarction.
|
J Thromb Thrombolysis
|
2000
|
0.78
|
|
129
|
Analysis of human leukemic cells by use of high-resolution two-dimensional electrophoresis. I: results of a pilot study.
|
Clin Chem
|
1983
|
0.78
|
|
130
|
Plasma fibrinogen and coronary heart disease in elderly Japanese-American men.
|
Arterioscler Thromb Vasc Biol
|
1996
|
0.77
|
|
131
|
Prostaglandin E1 does not accelerate rTPA-induced thrombolysis in acute myocardial infarction.
|
Am Heart J
|
1994
|
0.77
|
|
132
|
Alpha heavy-chain disease presenting as goiter.
|
Am J Clin Pathol
|
1984
|
0.77
|
|
133
|
Plasma fibrinogen and its correlates in elderly Japanese men living in Japan and Hawaii.
|
J Clin Epidemiol
|
1999
|
0.77
|
|
134
|
Two-dimensional gel electrophoresis as an aid in the analysis of monoclonal gammopathies.
|
Hum Pathol
|
1984
|
0.77
|
|
135
|
A quantitative trait locus on chromosome 5p influences d-dimer levels in the san antonio family heart study.
|
Int J Vasc Med
|
2010
|
0.76
|
|
136
|
Immunolocalization of noncollagenous bone matrix proteins in lumbar vertebrae from intact and surgically menopausal cynomolgus monkeys.
|
J Bone Miner Res
|
1993
|
0.76
|
|
137
|
Clinical applications of two-dimensional electrophoresis.
|
J Chromatogr A
|
1995
|
0.76
|
|
138
|
Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.
|
Am J Epidemiol
|
1996
|
0.76
|
|
139
|
New views on the relationship of plasma lipids to cardiovascular disease.
|
Circulation
|
1997
|
0.76
|
|
140
|
Cytokeratin expression in rat mesothelial cells in vitro is controlled by the extracellular matrix.
|
J Cell Sci
|
1990
|
0.76
|
|
141
|
Monitoring thrombolytic therapy.
|
Prog Cardiovasc Dis
|
1992
|
0.75
|
|
142
|
Precision evaluation of the Olympus "Demand" in clinical use.
|
Clin Chem
|
1987
|
0.75
|
|
143
|
A monoclonal-antibody-based radioimmunoassay for measurement of protein C in plasma.
|
Clin Chem
|
1988
|
0.75
|
|
144
|
An immunoenzyme assay for quantitation of human IgG antibodies to honeybee venom phospholipase A2.
|
J Immunol Methods
|
1980
|
0.75
|
|
145
|
Use of decreased reagent volumes in enzyme immunoassay.
|
Clin Chem
|
1979
|
0.75
|
|
146
|
Lipoprotein levels in elderly patients with asthma. Cardiovascular Health Study Research Group.
|
J Allergy Clin Immunol
|
1996
|
0.75
|
|
147
|
Radiolabeled ligand-binding phenomenon with 12-well microtiter strips.
|
Clin Chem
|
1988
|
0.75
|
|
148
|
Two-dimensional gel electrophoresis in the systematic development of new laboratory tests.
|
Ann N Y Acad Sci
|
1984
|
0.75
|
|
149
|
Development of monoclonal antibodies to proteins separated by two-dimensional gel electrophoresis.
|
J Immunol Methods
|
1983
|
0.75
|
|
150
|
Patterns for normal colon mucosa and colon adenocarcinoma compared by two-dimensional gel electrophoresis.
|
Clin Chem
|
1982
|
0.75
|
|
151
|
Instrumental developments in clinical chemistry.
|
Prog Clin Pathol
|
1981
|
0.75
|
|
152
|
A monoclonal antibody that inhibits activation of human Hageman factor (factor XII).
|
Blood
|
1985
|
0.75
|
|
153
|
Variability in plasma prothrombin concentration: implications for use in epidemiology.
|
Blood Coagul Fibrinolysis
|
1998
|
0.75
|
|
154
|
Reproducibility and quality assurance of two-dimensional gel electrophoresis of serum specimens.
|
Clin Chem
|
1982
|
0.75
|
|
155
|
Candidate genes and confirmed genetic polymorphisms associated with cardiovascular diseases: a tabular assessment.
|
J Thromb Thrombolysis
|
2001
|
0.75
|
|
156
|
Factor VII assays.
|
Arch Pathol Lab Med
|
1993
|
0.75
|
|
157
|
Colorimetric vs liquid-chromatographic determination of urinary 5-hydroxyindole-3-acetic acid.
|
Clin Chem
|
1981
|
0.75
|
|
158
|
Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial).
|
Am J Cardiol
|
1997
|
0.75
|
|
159
|
Studies on the measurement of protein S in plasma.
|
Clin Chem
|
1991
|
0.75
|
|
160
|
Heme-associated subunit complex of cytochrome c oxidase identified by a new two-dimensional gel electrophoresis.
|
J Biol Chem
|
1979
|
0.75
|